Reliance Capital Acquisition: Reliance Nippon Life Insurance, a subsidiary of debt-ridden Reliance Capital (RCAP), has began ...
BENGALURU, Aug 26 (Reuters) - India's Reliance Life Sciences has applied for regulatory approval to begin early stage human trials of its COVID-19 vaccine candidate, The Economic Times reported, opens ...